Personnel Information

写真a

ANDO Fumiaki


Job title

Assistant Professor

Campus Career 【 display / non-display

  • 1900.01
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Nephrology, Project Assistant Professor
  • 2017.04
    -
    2019.03
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Department of Internal Medicine, Nephrology, Project Assistant Professor
  • 2019.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Endowed Departments, Department of Nephrology and Regional Health(ibaraki), Assistant Professor
 

Published Papers & Misc 【 display / non-display

  • 1. Fujiki T, Ando F*, Murakami K, Isobe K, Mori T, Susa K, Nomura N, Sohara E, Rai T, Uchida S. Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation Scientific Reports. 2019.06; 9 (1): 9245.

  • 安藤 史顕, 内田 信一. 先天性腎性尿崩症の新規治療薬の開発 腎臓内科・泌尿器科. 2019.05; 9 (5): 457-463.

  • Ando F, Mori S, Yui N, Morimoto T, Nomura N, Sohara E, Rai T, Sasaki S, Kondo Y, Kagechika H, Uchida S.. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus Nature Communications. 2018.04; 9 (1): 1411.

  • Ando F, Uchida S.. Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus. Clin Exp Nephrol. . 2018.02;

  • Fumiaki Ando, Eisei Sohara, Tetsuji Morimoto, Naofumi Yui, Naohiro Nomura, Eriko Kikuchi, Daiei Takahashi, Takayasu Mori, Alain Vandewalle, Tatemitsu Rai, Sei Sasaki, Yoshiaki Kondo, Shinichi Uchida. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. Nat Commun. 2016.11; 7 13636. ( PubMed, DOI )

Conference Activities & Talks 【 display / non-display

  • Ando F, Yui N, Nomura N, Sohara E, Rai T, Sasaki S, Uchida S. AKAPs-PKA Disruptors Robustly Increase AQP2 Activity Independently of Vasopressin. The 52nd American Society of Nephrology, Kidney Week 2018 2018.10 San Diego

  • Ando F, Sohara E, Yui N, Nomura N, Kikuchi E, Takahashi D, Mori T, Rai T, Sasaki S, and Uchida S.. Calcineurin is a target for the treatment of nephrogenic diabetes insipidus. . 3rd Next Generation Kidney Research Meeting. 2016.08 Tokyo